Eric J Ende
CIK 1494386 · last filed 2026-02-12
Eric J Ende is a corporate insider who has filed 46 SEC Form 4 insider transactions across 5 companies since 2010. The most recent filing shows the insider disposed of $4.6M of AVDL on Feb 12, 2026. Across all open-market trades the lifetime net is +$1.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $93.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$93.7K
5
46
$1.08M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Director | 0 | $21.64 | $0 | $1.05M | 20 | 2026-02-12 |
| MTNB | Director | 120,092 | $0.78 | $93.7K | $26.9K | 19 | 2023-11-03 |
| NeuBase Therapeutics, Inc. (NBSE) Delisted | Director | — | $0.38 | — | $0 | 2 | 2022-09-12 |
| PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | Director | — | — | — | $0 | 2 | 2019-12-17 |
| GENZYME CORP (GENZ) Delisted | Director | 2,375 | — | — | $0 | 2 | 2011-04-06 |
Recent Filings
46 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-12 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Disp (D) | −219,905 | -$4.62M | EDGAR |
| 2025-07-31 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Grant (A) | +11,000 | $0 | EDGAR |
| 2025-01-14 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Buy (P) | +30,000 | $235.2K | EDGAR |
| 2024-08-01 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Grant (A) | +11,000 | $0 | EDGAR |
| 2023-11-03 | MTNB | Grant (A) | — | $0 | EDGAR |
| 2023-08-03 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-19 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Buy (P) | +13,000 | $181.1K | EDGAR |
| 2022-11-23 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Buy (P) | +20,000 | $156.1K | EDGAR |
| 2022-11-16 | MTNB | Grant (A) | — | $0 | EDGAR |
| 2022-09-12 | NeuBase Therapeutics, Inc. (NBSE) Delisted | Grant (A) | — | $0 | EDGAR |